Clinical Trial Update: Trajectories of FEV1 After Lung Transplantation

View source ↗

Summary

A clinical trial update shows that a study on trajectories of FEV1 after lung transplantation is currently enrolling by invitation. The sponsor is the Paris Tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Allograft Dysfunction
• Lung Allograft Rejection
• Lung Transplant Failure

Snippet

Sponsor: Paris Translational Research Center for Organ Transplantation | Conditions: Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction | Status: ENROLLING_BY_INVITATION